Cardiovascular Disease in Women and the Role of Hormone Replacement Therapy

Area of Science:

• Cardiology
• Endocrinology
• Women's Health

Background:

• Cardiovascular disease (CVD) is the primary cause of mortality in women, often presenting later and more severely than in men.
• Declining estrogen levels during menopause are strongly associated with elevated CVD risk.
• This link has spurred investigation into hormone replacement therapy (HRT) for managing menopausal symptoms and associated diseases like CVD.

Purpose of the Study:

• To review the biological changes during menopause and their specific impact on cardiovascular health in women.
• To examine the efficacy and safety of hormone replacement therapy (HRT) in women with CVD-related comorbidities.
• To outline the indications, potential risks, and contraindications for HRT in this population.

Main Methods:

• Literature review of studies on menopause, estrogen, CVD, and hormone replacement therapy.
• Analysis of biological mechanisms linking menopausal hormonal changes to cardiovascular alterations.
• Synthesis of clinical evidence regarding HRT's effects on CVD risk and comorbidities in postmenopausal women.

Main Results:

• Menopause-induced hormonal shifts contribute to adverse cardiovascular changes, increasing CVD risk.
• HRT may offer benefits in managing menopausal symptoms and potentially reducing CVD risk, though evidence varies.
• The decision to use HRT must be individualized, weighing potential benefits against risks and contraindications, especially in women with existing comorbidities.

Conclusions:

• Understanding the interplay between menopause and CVD is crucial for women's cardiovascular health.
• Hormone replacement therapy (HRT) presents a potential intervention but requires careful patient selection and monitoring.
• Further research is needed to fully elucidate HRT's role in CVD prevention and management in diverse female populations.